ロード中...
Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody
PURPOSE: Erlotinib is a novel therapeutic agent for cancer treatment. This study was performed to investigate the role of c-MET-PI3K-AKT pathway in the regulation of erlotinib-induced radiosensitization. METHODS: A973 lung adenocarcinoma cells treated with 6 Gy of radiation were incubated in the pre...
保存先:
| 出版年: | Cancer Cell Int |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4263203/ https://ncbi.nlm.nih.gov/pubmed/25505849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-014-0109-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|